MEDICAL ETHICS:@0.099415:0.051227:0.278670:0.051227:0.278670:0.029663:0.099415:0.029663:0.020855:0.012164:0.016884:0.005129:0.018450:0.016793:0.010484:0.006286:0.012164:0.009667:0.015500:0.005129:0.018450:0.011301
36:@0.040417:0.051430:0.060750:0.051430:0.060750:0.028888:0.040417:0.028888:0.010167:0.010167
HAnDBook oF MEDICAL ETHICS:@0.099415:0.959549:0.357162:0.959549:0.357162:0.943867:0.099415:0.943867:0.011272:0.012213:0.012213:0.012279:0.009473:0.014342:0.014342:0.009754:0.004572:0.014342:0.008005:0.004572:0.015167:0.008846:0.012279:0.003730:0.013418:0.012213:0.007625:0.004572:0.008846:0.007031:0.011272:0.003730:0.013418:0.008219
Prof jacques Snyman:@0.098830:0.184374:0.291559:0.184374:0.291559:0.165931:0.098830:0.165931:0.010398:0.005942:0.011883:0.005199:0.005199:0.008912:0.012254:0.011883:0.012254:0.011140:0.011883:0.008170:0.005199:0.009655:0.011140:0.010769:0.017453:0.012254:0.011140
MD:@0.098830:0.200172:0.128538:0.200172:0.128538:0.181728:0.098830:0.181728:0.016711:0.012997
 :@0.098830:0.214588:0.133941:0.214588:0.133941:0.200262:0.098830:0.200262:0.016543:0.018567
CEo: ISIMo Health, Durbanville,  :@0.133941:0.215827:0.420787:0.215827:0.420787:0.198184:0.133941:0.198184:0.014910:0.009766:0.015949:0.004957:0.004957:0.004011:0.009061:0.004011:0.016878:0.015949:0.004957:0.012496:0.011883:0.012496:0.003528:0.006109:0.011140:0.004957:0.004957:0.013628:0.011103:0.005403:0.012477:0.012496:0.011140:0.010101:0.003528:0.003528:0.003528:0.011883:0.005143:0.004772:0.005143
Cape Town:@0.098830:0.231483:0.201823:0.231483:0.201823:0.213839:0.098830:0.213839:0.014910:0.012496:0.012477:0.011883:0.004957:0.007724:0.011976:0.015244:0.011326
“Biologicals” is a term coined to describe :@0.098830:0.262949:0.481242:0.262949:0.481242:0.245306:0.098830:0.245306:0.009376:0.010713:0.003769:0.012217:0.003769:0.012217:0.012551:0.003769:0.012069:0.012737:0.003769:0.007260:0.009042:0.006220:0.003769:0.007260:0.006220:0.012737:0.006220:0.006350:0.012124:0.005644:0.017472:0.006220:0.012069:0.012217:0.003769:0.011382:0.012124:0.012774:0.006220:0.006350:0.012217:0.006220:0.012774:0.012124:0.007260:0.012069:0.005644:0.003769:0.012719:0.012069:0.005143
medicines made by replicating endoge-:@0.098830:0.278746:0.475857:0.278746:0.475857:0.261103:0.098830:0.261103:0.017620:0.012273:0.012923:0.003918:0.012217:0.003918:0.011530:0.012273:0.007408:0.006369:0.017620:0.012886:0.012923:0.012273:0.006369:0.012867:0.010156:0.006369:0.005793:0.012273:0.012867:0.003918:0.003918:0.012217:0.012886:0.006499:0.003918:0.011530:0.012700:0.006369:0.012273:0.011530:0.012923:0.012366:0.012700:0.012273:0.006164
nous peptides or proteins or targeting these :@0.098830:0.294544:0.481205:0.294544:0.481205:0.276901:0.098830:0.276901:0.011140:0.011976:0.011103:0.007018:0.004048:0.012477:0.011883:0.012477:0.006109:0.003528:0.012533:0.011883:0.007018:0.004048:0.011976:0.005403:0.004048:0.012477:0.005403:0.011976:0.006109:0.011883:0.003528:0.011140:0.007018:0.004048:0.011976:0.005403:0.004048:0.006109:0.012496:0.005403:0.012310:0.011883:0.006109:0.003528:0.011140:0.012310:0.004048:0.006109:0.011140:0.011883:0.007018:0.012069:0.005143
by manufacturing antibodies against the :@0.098830:0.310341:0.481149:0.310341:0.481149:0.292698:0.098830:0.292698:0.012811:0.010101:0.006313:0.017546:0.012830:0.011456:0.011419:0.005979:0.012830:0.012162:0.006424:0.011419:0.005719:0.003862:0.011456:0.012626:0.006313:0.012830:0.011456:0.006424:0.003862:0.012811:0.012292:0.012867:0.003862:0.012199:0.007353:0.006313:0.012830:0.012626:0.012830:0.003862:0.011456:0.007353:0.006424:0.006313:0.006424:0.011456:0.012069:0.005143
receptor sites. There currently exist a myriad :@0.098830:0.326139:0.481168:0.326139:0.481168:0.308496:0.098830:0.308496:0.005403:0.011883:0.011827:0.011883:0.012477:0.006109:0.011976:0.005403:0.004103:0.007018:0.003528:0.006109:0.011883:0.007018:0.004957:0.004103:0.007724:0.011140:0.011883:0.005403:0.011883:0.004103:0.011827:0.011103:0.005403:0.005403:0.011883:0.011140:0.006109:0.003528:0.009766:0.004103:0.011883:0.008727:0.003528:0.007018:0.006109:0.004103:0.012496:0.004103:0.017230:0.009766:0.005403:0.003528:0.012496:0.012719:0.005143
examples of these so-called biologicals as :@0.098830:0.341937:0.480945:0.341937:0.480945:0.324293:0.098830:0.324293:0.011920:0.008764:0.012533:0.017268:0.012514:0.003565:0.011920:0.007056:0.006016:0.012013:0.005682:0.006016:0.006146:0.011177:0.011920:0.007056:0.011920:0.006016:0.007056:0.012013:0.006016:0.011864:0.012533:0.003565:0.003565:0.011920:0.012570:0.006016:0.012514:0.003565:0.012013:0.003565:0.012013:0.012347:0.003565:0.011864:0.012533:0.003565:0.007056:0.006016:0.012533:0.007204:0.005143
they constitute the current trend away :@0.098830:0.357734:0.481112:0.357734:0.481112:0.340091:0.098830:0.340091:0.006981:0.012013:0.012756:0.010639:0.006851:0.012700:0.012849:0.012013:0.007891:0.006981:0.004400:0.006981:0.011976:0.006981:0.012756:0.006851:0.006981:0.012013:0.012756:0.006851:0.012700:0.011976:0.006276:0.006276:0.012756:0.012013:0.006981:0.006851:0.006981:0.006276:0.012756:0.012013:0.013406:0.006851:0.013368:0.016116:0.013368:0.009952:0.005143
from simpler, small chemical entities for the :@0.098830:0.373532:0.481130:0.373532:0.481130:0.355888:0.098830:0.355888:0.005644:0.005403:0.011976:0.017230:0.005013:0.007018:0.003528:0.017230:0.012477:0.003528:0.011883:0.005403:0.004957:0.005013:0.007018:0.017230:0.012496:0.003528:0.003528:0.005013:0.011827:0.011140:0.011883:0.017230:0.003528:0.011827:0.012496:0.003528:0.005013:0.011883:0.011140:0.006109:0.003528:0.006109:0.003528:0.011883:0.007018:0.005013:0.005644:0.011976:0.005403:0.005013:0.006109:0.011140:0.012069:0.005143
treatment of many so-called orphan and :@0.098830:0.389329:0.481168:0.389329:0.481168:0.371686:0.098830:0.371686:0.006350:0.005644:0.012124:0.012737:0.006350:0.017472:0.012124:0.011382:0.006350:0.006220:0.012217:0.005886:0.006220:0.017472:0.012737:0.011382:0.010008:0.006220:0.007260:0.012217:0.006220:0.012069:0.012737:0.003769:0.003769:0.012124:0.012774:0.006220:0.012217:0.005644:0.012719:0.011382:0.012737:0.011382:0.006220:0.012737:0.011382:0.012719:0.005143
often previously untreatable conditions, :@0.098830:0.405127:0.481335:0.405127:0.481335:0.387484:0.098830:0.387484:0.012626:0.006294:0.006758:0.012533:0.011790:0.006629:0.013127:0.006053:0.012533:0.010750:0.004178:0.012626:0.011753:0.007668:0.004178:0.010416:0.006629:0.011753:0.011790:0.006758:0.006053:0.012533:0.013146:0.006758:0.013146:0.013127:0.004178:0.012533:0.006629:0.012477:0.012626:0.011790:0.013183:0.004178:0.006758:0.004178:0.012626:0.011790:0.007668:0.005143:0.005143
such enzyme storage diseases and cancer. :@0.098830:0.420924:0.481186:0.420924:0.481186:0.403281:0.098830:0.403281:0.007018:0.011103:0.011827:0.011140:0.004011:0.011883:0.011140:0.007705:0.009766:0.017230:0.011883:0.004011:0.007018:0.006109:0.011976:0.005403:0.012496:0.012310:0.011883:0.004011:0.012533:0.003528:0.007018:0.011883:0.012496:0.007018:0.011883:0.007018:0.004011:0.012496:0.011140:0.012533:0.004011:0.011827:0.012496:0.011140:0.011827:0.011883:0.005403:0.005143:0.005143
However, exciting as this may sound, only a :@0.098830:0.436722:0.481205:0.436722:0.481205:0.419079:0.098830:0.419079:0.012496:0.011976:0.015244:0.011883:0.010101:0.011883:0.005403:0.004957:0.004215:0.011883:0.008727:0.011827:0.003528:0.006109:0.003528:0.011140:0.012310:0.004233:0.012496:0.007018:0.004233:0.006109:0.011140:0.003528:0.007018:0.004233:0.017230:0.012496:0.009766:0.004233:0.007018:0.011976:0.011103:0.011140:0.012533:0.004957:0.004233:0.011976:0.011140:0.003528:0.009766:0.004233:0.012681:0.005143
privileged few are able to afford these :@0.098830:0.452519:0.481001:0.452519:0.481001:0.434876:0.098830:0.434876:0.013294:0.006220:0.004345:0.010918:0.004345:0.004345:0.012700:0.013127:0.012700:0.013350:0.006796:0.006461:0.012700:0.016061:0.006796:0.013313:0.006220:0.012700:0.006796:0.013313:0.013294:0.004345:0.012700:0.006796:0.006926:0.012793:0.006796:0.013313:0.006461:0.006461:0.012793:0.006220:0.013350:0.006796:0.006926:0.011957:0.012700:0.007835:0.012069:0.005143
rather expensive new entities for the treat-:@0.098830:0.468317:0.476025:0.468317:0.476025:0.450674:0.098830:0.450674:0.005403:0.012514:0.006109:0.011140:0.011883:0.005403:0.005997:0.011883:0.008745:0.012496:0.011883:0.011140:0.007037:0.003546:0.010119:0.011883:0.005997:0.011140:0.011883:0.015262:0.005997:0.011883:0.011140:0.006109:0.003546:0.006109:0.003546:0.011883:0.007037:0.005997:0.005644:0.011976:0.005403:0.005997:0.006109:0.011140:0.011883:0.005997:0.006109:0.005403:0.011883:0.012514:0.006257:0.006164
ment of their diseases. :@0.098830:0.484115:0.299413:0.484115:0.299413:0.466471:0.098830:0.466471:0.017230:0.011883:0.011140:0.006109:0.004957:0.011976:0.005644:0.004957:0.006109:0.011140:0.011883:0.003528:0.005403:0.004957:0.012533:0.003528:0.007018:0.011883:0.012496:0.007018:0.011883:0.007018:0.005143:0.005143
An example of an older biological :@0.116377:0.499912:0.481149:0.499912:0.481149:0.482269:0.116377:0.482269:0.015207:0.012793:0.007631:0.013536:0.010379:0.014148:0.018883:0.014130:0.005180:0.013536:0.007631:0.013628:0.007297:0.007631:0.014148:0.012793:0.007631:0.013628:0.005180:0.014185:0.013536:0.007056:0.007631:0.014130:0.005180:0.013628:0.005180:0.013628:0.013963:0.005180:0.013480:0.014148:0.003713:0.005143
medicine is insulin. Insulin has revolution-:@0.098830:0.515710:0.476136:0.515710:0.476136:0.498066:0.098830:0.498066:0.017750:0.012403:0.013053:0.004048:0.012347:0.004048:0.011660:0.012403:0.006499:0.004048:0.007538:0.006499:0.004048:0.011660:0.007538:0.011623:0.004048:0.004048:0.011660:0.005477:0.006499:0.004530:0.011660:0.007538:0.011623:0.004048:0.004048:0.011660:0.006499:0.011660:0.013016:0.007538:0.006499:0.005904:0.012403:0.010620:0.012496:0.004048:0.011623:0.006629:0.004048:0.012496:0.011660:0.006164
ised the treatment of diabetes mellitus, :@0.098830:0.531507:0.481316:0.531507:0.481316:0.513864:0.098830:0.513864:0.004308:0.007798:0.012663:0.013313:0.006758:0.006888:0.011920:0.012663:0.006758:0.006888:0.006164:0.012663:0.013276:0.006888:0.018010:0.012663:0.011920:0.006888:0.006758:0.012737:0.006424:0.006758:0.013313:0.004308:0.013276:0.013257:0.012663:0.006888:0.012663:0.007798:0.006758:0.018010:0.012663:0.004308:0.004308:0.004308:0.006888:0.011883:0.007798:0.005143:0.005143
becoming an affordable and sustainable :@0.098830:0.547305:0.481242:0.547305:0.481242:0.529662:0.098830:0.529662:0.012700:0.012106:0.012050:0.012180:0.017453:0.003751:0.011345:0.012533:0.006201:0.012719:0.011363:0.006201:0.012719:0.005867:0.005867:0.012180:0.005607:0.012756:0.012719:0.012700:0.003751:0.012087:0.006201:0.012719:0.011363:0.012756:0.006201:0.007241:0.011326:0.007241:0.006313:0.012719:0.003751:0.011345:0.012719:0.012700:0.003751:0.012069:0.005143
therapy option for any diabetic patient :@0.098830:0.563102:0.481186:0.563102:0.481186:0.545459:0.098830:0.545459:0.006796:0.011827:0.012570:0.006090:0.013183:0.013164:0.010453:0.006666:0.012663:0.013164:0.006796:0.004215:0.012663:0.011827:0.006666:0.006331:0.012663:0.006090:0.006666:0.013183:0.011827:0.010453:0.006666:0.013220:0.004215:0.013183:0.013164:0.012570:0.006796:0.004215:0.012514:0.006666:0.013164:0.013183:0.006796:0.004215:0.012570:0.011827:0.006294:0.005143
requiring a significant reduction of blood :@0.098830:0.578900:0.481001:0.578900:0.481001:0.561257:0.098830:0.561257:0.005756:0.012236:0.012830:0.011456:0.003881:0.005756:0.003881:0.011493:0.012663:0.006331:0.012849:0.006331:0.007371:0.003881:0.012663:0.011493:0.003881:0.004605:0.004605:0.012180:0.012849:0.011493:0.006461:0.006331:0.005756:0.012236:0.012886:0.011456:0.012180:0.006461:0.003881:0.012329:0.011493:0.006331:0.012329:0.005997:0.006331:0.012830:0.003881:0.012329:0.012329:0.012719:0.005143
glucose levels and for the prevention of :@0.098830:0.594697:0.480982:0.594697:0.480982:0.577054:0.098830:0.577054:0.012867:0.004085:0.011660:0.012384:0.012533:0.007575:0.012440:0.006536:0.004085:0.012440:0.010658:0.012440:0.004085:0.007575:0.006554:0.013053:0.011697:0.013090:0.006536:0.006201:0.012533:0.005960:0.006554:0.006666:0.011697:0.012440:0.006554:0.013034:0.005960:0.012440:0.010658:0.012440:0.011697:0.006666:0.004085:0.012533:0.011697:0.006536:0.012533:0.005830:0.005143
typical diabetic complications associated :@0.098830:0.610495:0.481149:0.610495:0.481149:0.592852:0.098830:0.592852:0.006294:0.009952:0.012663:0.003713:0.012013:0.012681:0.003713:0.004827:0.012719:0.003713:0.012681:0.012663:0.012069:0.006294:0.003713:0.012013:0.004809:0.012013:0.012162:0.017416:0.012663:0.003713:0.003713:0.012013:0.012681:0.006294:0.003713:0.012162:0.011326:0.007204:0.004827:0.012681:0.007204:0.007204:0.012162:0.012013:0.003713:0.012681:0.006294:0.012069:0.012719:0.005143
with an uncontrolled disease. Insulin is :@0.098830:0.626293:0.481186:0.626293:0.481186:0.608649:0.098830:0.608649:0.016321:0.004605:0.007186:0.012217:0.007056:0.013573:0.012217:0.007056:0.012180:0.012217:0.012904:0.013053:0.012217:0.007186:0.006480:0.013053:0.004605:0.004605:0.012960:0.013610:0.007056:0.013610:0.004605:0.008095:0.012960:0.013573:0.008095:0.012960:0.006034:0.007056:0.005087:0.012217:0.008095:0.012180:0.004605:0.004605:0.012217:0.007056:0.004605:0.007204:0.005143
therefore an essential medicine, accord- :@0.098830:0.642090:0.481168:0.642090:0.481168:0.624447:0.098830:0.624447:0.006443:0.011475:0.012217:0.005737:0.012217:0.005979:0.012310:0.005737:0.012217:0.006313:0.012830:0.011475:0.006313:0.012217:0.007353:0.007353:0.012217:0.011475:0.006443:0.003862:0.012830:0.003862:0.006313:0.017565:0.012217:0.012867:0.003862:0.012162:0.003862:0.011475:0.012217:0.005292:0.006313:0.012830:0.012162:0.012162:0.012310:0.005737:0.012867:0.006109:0.005143
ing to the WHo list. However, not all insulins :@0.098830:0.657888:0.481149:0.657888:0.481149:0.640244:0.098830:0.640244:0.003713:0.011326:0.012496:0.004252:0.006294:0.012162:0.004252:0.006294:0.011326:0.012069:0.004252:0.017825:0.012681:0.016135:0.004252:0.003713:0.003713:0.007204:0.006294:0.005143:0.004252:0.012681:0.012162:0.015429:0.012069:0.010286:0.012069:0.005589:0.005143:0.004233:0.011326:0.012162:0.006294:0.004233:0.012681:0.003713:0.003713:0.004252:0.003713:0.011326:0.007204:0.011289:0.003713:0.003713:0.011326:0.007204:0.005143
are on this list, e.g., insulin analogues. This :@0.098830:0.673685:0.481316:0.673685:0.481316:0.656042:0.098830:0.656042:0.012737:0.005644:0.012124:0.006220:0.012217:0.011382:0.006220:0.006350:0.011382:0.003769:0.007260:0.006220:0.003769:0.003769:0.007260:0.006350:0.005199:0.006220:0.012124:0.005199:0.012551:0.005199:0.005199:0.006220:0.003769:0.011382:0.007260:0.011345:0.003769:0.003769:0.011382:0.006220:0.012737:0.011382:0.012737:0.003769:0.012217:0.012551:0.011345:0.012124:0.007260:0.005199:0.006220:0.007965:0.011382:0.003769:0.007204:0.005143
immediately prompts the question as to :@0.098830:0.689483:0.481093:0.689483:0.481093:0.671840:0.098830:0.671840:0.004141:0.017843:0.017843:0.012496:0.013146:0.004141:0.013108:0.006721:0.012496:0.004141:0.010379:0.006591:0.013090:0.006016:0.012589:0.017843:0.013090:0.006721:0.007631:0.006591:0.006721:0.011753:0.012496:0.006591:0.013090:0.011716:0.012496:0.007631:0.006721:0.004141:0.012589:0.011753:0.006591:0.013108:0.007631:0.006591:0.006721:0.012162:0.005143
why other more expensive drugs, some :@0.098830:0.705280:0.481223:0.705280:0.481223:0.687637:0.098830:0.687637:0.016042:0.011939:0.010565:0.006777:0.012774:0.006907:0.011939:0.012681:0.006201:0.006777:0.018029:0.012774:0.006201:0.012681:0.006777:0.012681:0.009525:0.013276:0.012681:0.011939:0.007817:0.004326:0.010899:0.012681:0.006777:0.013331:0.006201:0.011902:0.013108:0.007817:0.005756:0.006777:0.007817:0.012774:0.018029:0.012069:0.005143
even considered to be life-saving, are not :@0.098830:0.721078:0.481168:0.721078:0.481168:0.703435:0.098830:0.703435:0.012069:0.010286:0.012069:0.011326:0.005366:0.012013:0.012162:0.011326:0.007204:0.003713:0.012719:0.012069:0.005589:0.012069:0.012719:0.005366:0.006294:0.012162:0.005366:0.012663:0.012069:0.005366:0.003713:0.003713:0.005830:0.012069:0.006164:0.007204:0.012681:0.010305:0.003713:0.011326:0.012496:0.005143:0.005366:0.012681:0.005589:0.012069:0.005366:0.011326:0.012162:0.006294:0.005143
listed. The answer is simple: price and :@0.098830:0.736875:0.481130:0.736875:0.481130:0.719232:0.098830:0.719232:0.004716:0.004716:0.008207:0.007297:0.013071:0.013721:0.006146:0.007167:0.008912:0.012329:0.013071:0.007167:0.013684:0.012329:0.008207:0.016432:0.013071:0.006591:0.007167:0.004716:0.008207:0.007167:0.008207:0.004716:0.018419:0.013666:0.004716:0.013071:0.006146:0.007167:0.013666:0.006591:0.004716:0.013016:0.013071:0.007167:0.013684:0.012329:0.012719:0.005143
affordability. The cost to develop these :@0.098830:0.752673:0.481279:0.752673:0.481279:0.735030:0.098830:0.735030:0.013238:0.006387:0.006387:0.012719:0.006146:0.013276:0.013238:0.013220:0.004270:0.004270:0.004270:0.006851:0.010509:0.005700:0.006721:0.008467:0.011883:0.012626:0.006721:0.012570:0.012719:0.007761:0.006851:0.006721:0.006851:0.012719:0.006721:0.013276:0.012626:0.010843:0.012626:0.004270:0.012719:0.013220:0.006721:0.006851:0.011883:0.012626:0.007761:0.012069:0.005143
newer agents far outweighs that of the :@0.098830:0.768471:0.481168:0.768471:0.481168:0.750827:0.098830:0.750827:0.011902:0.012644:0.016005:0.012644:0.006164:0.006740:0.013257:0.013071:0.012644:0.011902:0.006870:0.007780:0.006740:0.006406:0.013257:0.006164:0.006740:0.012737:0.011864:0.006870:0.016005:0.012644:0.004289:0.013071:0.011902:0.007780:0.006740:0.006870:0.011902:0.013257:0.006870:0.006740:0.012737:0.006406:0.006740:0.006870:0.011902:0.012069:0.005143
smaller molecules, most of which were :@0.098830:0.784268:0.481168:0.784268:0.481168:0.766625:0.098830:0.766625:0.007965:0.018177:0.013443:0.004475:0.004475:0.012811:0.006331:0.006926:0.018177:0.012904:0.004475:0.012811:0.012774:0.012050:0.004475:0.012811:0.007965:0.005886:0.006926:0.018177:0.012904:0.007965:0.007037:0.006926:0.012904:0.006591:0.006926:0.016191:0.012069:0.004475:0.012774:0.012069:0.006926:0.016191:0.012811:0.006331:0.012069:0.005143
developed during the past 30 years. :@0.098830:0.800066:0.481168:0.800066:0.481168:0.782422:0.098830:0.782422:0.014093:0.013443:0.011679:0.013443:0.005106:0.013536:0.014055:0.013443:0.014093:0.007557:0.014111:0.012663:0.006963:0.005106:0.012700:0.013870:0.007557:0.007668:0.012700:0.013443:0.007557:0.014055:0.014074:0.008597:0.007668:0.007557:0.011679:0.011679:0.007557:0.011345:0.013443:0.014055:0.006963:0.008597:0.005143:0.005143
Development costs and risks are high as :@0.098830:0.815863:0.481260:0.815863:0.481260:0.798220:0.098830:0.798220:0.014148:0.012403:0.010620:0.012403:0.004048:0.012496:0.012997:0.017750:0.012403:0.011660:0.006629:0.006499:0.012347:0.012496:0.007538:0.006629:0.007538:0.006499:0.013016:0.011660:0.013053:0.006499:0.005923:0.004048:0.007538:0.009655:0.007538:0.006499:0.013016:0.005923:0.012403:0.006499:0.011660:0.004048:0.012830:0.011660:0.006499:0.013016:0.007204:0.005143
many of the target medicines fail clinical :@0.098830:0.831661:0.481075:0.831661:0.481075:0.814018:0.098830:0.814018:0.017528:0.012793:0.011437:0.010063:0.006276:0.012273:0.005942:0.006276:0.006406:0.011437:0.012180:0.006276:0.006406:0.012793:0.005700:0.012607:0.012180:0.006406:0.006276:0.017528:0.012180:0.012830:0.003825:0.012124:0.003825:0.011437:0.012180:0.007316:0.006276:0.005942:0.012793:0.003825:0.003825:0.006276:0.012124:0.003825:0.003825:0.011437:0.003825:0.012124:0.012793:0.003713:0.005143
scrutiny  during  early-phase  clinical :@0.098830:0.847458:0.480963:0.847458:0.480963:0.829815:0.098830:0.829815:0.009061:0.013870:0.007445:0.013146:0.008151:0.005570:0.013183:0.011809:0.005143:0.002878:0.014575:0.013146:0.007445:0.005570:0.013183:0.014352:0.005143:0.002878:0.013925:0.014538:0.007445:0.005570:0.011809:0.008021:0.014520:0.013183:0.014538:0.009061:0.013925:0.005143:0.002878:0.013870:0.005570:0.005570:0.013183:0.005570:0.013870:0.014538:0.003713:0.005143
research. The main reasons for failure are :@0.098830:0.863256:0.481168:0.863256:0.481168:0.845613:0.098830:0.845613:0.005663:0.012143:0.007278:0.012143:0.012756:0.005663:0.012087:0.011400:0.005217:0.006239:0.007984:0.011400:0.012143:0.006239:0.017490:0.012756:0.003788:0.011400:0.006239:0.005663:0.012143:0.012756:0.007278:0.012236:0.011400:0.007278:0.006239:0.005904:0.012236:0.005663:0.006239:0.005904:0.012756:0.003788:0.003788:0.011363:0.005663:0.012143:0.006239:0.012756:0.005663:0.012069:0.005143
adverse effects due to the mode of :@0.098830:0.879053:0.481093:0.879053:0.481093:0.861410:0.098830:0.861410:0.014185:0.014223:0.011790:0.013573:0.007093:0.008708:0.013573:0.007668:0.013573:0.007334:0.007334:0.013573:0.013517:0.007798:0.008708:0.007668:0.014223:0.012793:0.013573:0.007668:0.007798:0.013666:0.007668:0.007798:0.012830:0.013573:0.007668:0.018920:0.013666:0.014223:0.013573:0.007668:0.013666:0.005830:0.005143
action or unintended side effects because :@0.098830:0.894851:0.481168:0.894851:0.481168:0.877208:0.098830:0.877208:0.012681:0.012013:0.006294:0.003713:0.012162:0.011326:0.003881:0.012162:0.005589:0.003881:0.011289:0.011326:0.003713:0.011326:0.006294:0.012069:0.011326:0.012719:0.012069:0.012719:0.003881:0.007204:0.003713:0.012719:0.012069:0.003881:0.012069:0.005830:0.005830:0.012069:0.012013:0.006294:0.007204:0.003881:0.012663:0.012069:0.012013:0.012681:0.011289:0.007204:0.012069:0.005143
of the peptide type or the undesired anti-:@0.098830:0.910649:0.476025:0.910649:0.476025:0.893005:0.098830:0.893005:0.012162:0.005830:0.005719:0.006294:0.011326:0.012069:0.005719:0.012663:0.012069:0.012663:0.006294:0.003713:0.012719:0.012069:0.005719:0.006294:0.009952:0.012663:0.012069:0.005719:0.012162:0.005589:0.005719:0.006294:0.011326:0.012069:0.005719:0.011289:0.011326:0.012719:0.012069:0.007204:0.003713:0.005589:0.012069:0.012719:0.005719:0.012681:0.011326:0.006294:0.003713:0.006164
genicity of the new entity. The latter may :@0.098830:0.926446:0.481038:0.926446:0.481038:0.908803:0.098830:0.908803:0.012570:0.012143:0.011400:0.003788:0.012087:0.003788:0.006369:0.010026:0.006239:0.012236:0.005904:0.006239:0.006369:0.011400:0.012143:0.006239:0.011400:0.012143:0.015504:0.006239:0.012143:0.011400:0.006369:0.003788:0.006369:0.010026:0.005217:0.006239:0.007984:0.011400:0.012143:0.006239:0.003788:0.012756:0.006369:0.006369:0.012143:0.005663:0.006239:0.017490:0.012756:0.009952:0.005143
lead to neutralising antibodies which :@0.522814:0.184090:0.905133:0.184090:0.905133:0.166447:0.522814:0.166447:0.004920:0.013257:0.013888:0.013907:0.007371:0.007483:0.013350:0.007371:0.012514:0.013257:0.012477:0.007483:0.006777:0.013888:0.004920:0.004920:0.008411:0.004920:0.012514:0.013684:0.007371:0.013888:0.012514:0.007483:0.004920:0.013870:0.013350:0.013925:0.004920:0.013257:0.008411:0.007371:0.016618:0.012514:0.004920:0.013201:0.011326:0.005143
render the medicine inactive, or – even :@0.522814:0.199888:0.905281:0.199888:0.905281:0.182244:0.522814:0.182244:0.006016:0.012496:0.011753:0.013146:0.012496:0.006016:0.006591:0.006721:0.011753:0.012496:0.006591:0.017843:0.012496:0.013146:0.004141:0.012440:0.004141:0.011753:0.012496:0.006591:0.004141:0.011753:0.013108:0.012440:0.006721:0.004141:0.010713:0.012496:0.005570:0.006591:0.012589:0.006016:0.006591:0.009711:0.006591:0.012496:0.010713:0.012496:0.011326:0.005143
more devastating – to anaphylactic shock :@0.522814:0.215685:0.905151:0.215685:0.905151:0.198042:0.522814:0.198042:0.017416:0.012162:0.005589:0.012069:0.004270:0.012719:0.012069:0.010286:0.012681:0.007204:0.006294:0.012681:0.006294:0.003713:0.011326:0.012496:0.004270:0.009284:0.004270:0.006294:0.012162:0.004270:0.012681:0.011326:0.012681:0.012663:0.011326:0.009952:0.003713:0.012681:0.012013:0.006294:0.003713:0.012013:0.004289:0.007204:0.011326:0.012162:0.012013:0.009321:0.005143
or target organ damage due to an :@0.522814:0.231483:0.905077:0.231483:0.905077:0.213839:0.522814:0.213839:0.013907:0.007334:0.007910:0.008040:0.014427:0.007334:0.014241:0.013814:0.008040:0.007910:0.013907:0.007334:0.014241:0.014427:0.013071:0.007910:0.014464:0.014427:0.019161:0.014427:0.014241:0.013814:0.007910:0.014464:0.013034:0.013814:0.007910:0.008040:0.013907:0.007910:0.014427:0.011326:0.005143
immune mechanism triggered by the now :@0.522814:0.247280:0.905151:0.247280:0.905151:0.229637:0.522814:0.229637:0.003713:0.017416:0.017416:0.011289:0.011326:0.012069:0.004902:0.017416:0.012069:0.012013:0.011326:0.012681:0.011326:0.003713:0.007204:0.017416:0.004920:0.006294:0.005589:0.003713:0.012496:0.012496:0.012069:0.005589:0.012069:0.012700:0.004920:0.012663:0.009952:0.004920:0.006294:0.011326:0.012069:0.004902:0.011326:0.012162:0.015429:0.005143
foreign protein or peptides. In order for :@0.522814:0.263078:0.905225:0.263078:0.905225:0.245435:0.522814:0.245435:0.006424:0.012756:0.006183:0.012663:0.004308:0.013090:0.011920:0.006758:0.013257:0.006183:0.012756:0.006888:0.012663:0.004308:0.011920:0.006758:0.012756:0.006183:0.006758:0.013257:0.012663:0.013257:0.006888:0.004308:0.013313:0.012663:0.007798:0.005737:0.006758:0.004790:0.011920:0.006758:0.012756:0.006183:0.013313:0.012663:0.006183:0.006758:0.006424:0.012756:0.005589:0.005143
patients to gain broader access to these :@0.522814:0.278875:0.905003:0.278875:0.905003:0.261232:0.522814:0.261232:0.012793:0.012811:0.006424:0.003843:0.012199:0.011456:0.006424:0.007334:0.006294:0.006424:0.012292:0.006294:0.012626:0.012811:0.003843:0.011456:0.006294:0.012793:0.005719:0.012292:0.012811:0.012849:0.012199:0.005719:0.006294:0.012811:0.012143:0.012143:0.012199:0.007334:0.007334:0.006294:0.006424:0.012292:0.006294:0.006424:0.011456:0.012199:0.007334:0.012069:0.005143
biologicals they had to wait for patent :@0.522814:0.294673:0.905133:0.294673:0.905133:0.277030:0.522814:0.277030:0.013350:0.004400:0.012849:0.004400:0.012849:0.013183:0.004400:0.012700:0.013368:0.004400:0.007891:0.006851:0.006981:0.012013:0.012756:0.010639:0.006851:0.012013:0.013368:0.013406:0.006851:0.006981:0.012849:0.006851:0.016116:0.013368:0.004400:0.006981:0.006851:0.006517:0.012849:0.006276:0.006851:0.013350:0.013368:0.006981:0.012756:0.012013:0.006294:0.005143
expiry and for other manufacturers to start :@0.522814:0.310470:0.905151:0.310470:0.905151:0.292827:0.522814:0.292827:0.012069:0.008912:0.012663:0.003713:0.005589:0.009952:0.004809:0.012681:0.011326:0.012719:0.004790:0.005830:0.012162:0.005589:0.004790:0.012162:0.006294:0.011326:0.012069:0.005589:0.004790:0.017416:0.012681:0.011326:0.011289:0.005830:0.012681:0.012013:0.006294:0.011289:0.005589:0.012069:0.005589:0.007204:0.004790:0.006294:0.012162:0.004790:0.007204:0.006294:0.012681:0.005589:0.006294:0.005143
producing the same or similar medical :@0.522814:0.326268:0.905188:0.326268:0.905188:0.308625:0.522814:0.308625:0.013424:0.006331:0.012904:0.013480:0.012050:0.012774:0.004475:0.012069:0.013257:0.006926:0.007037:0.012087:0.012830:0.006926:0.007965:0.013443:0.018177:0.012830:0.006926:0.012904:0.006331:0.006926:0.007965:0.004475:0.018177:0.004475:0.004475:0.013443:0.006331:0.006926:0.018177:0.012830:0.013480:0.004475:0.012774:0.013443:0.003713:0.005143
entities at a cheaper price. The develop-:@0.522814:0.342066:0.899860:0.342066:0.899860:0.324422:0.522814:0.324422:0.012143:0.011400:0.006369:0.003788:0.006369:0.003788:0.012143:0.007278:0.006239:0.012756:0.006369:0.006239:0.012756:0.006239:0.012087:0.011400:0.012143:0.012756:0.012737:0.012143:0.005663:0.006239:0.012737:0.005663:0.003788:0.012087:0.012143:0.005217:0.006239:0.007984:0.011400:0.012143:0.006239:0.012793:0.012143:0.010361:0.012143:0.003788:0.012236:0.012737:0.006164
ment of these products was rapid, as :@0.522814:0.357863:0.904984:0.357863:0.904984:0.340220:0.522814:0.340220:0.018512:0.013164:0.012422:0.007390:0.007260:0.013257:0.006926:0.007260:0.007390:0.012422:0.013164:0.008300:0.013164:0.007260:0.013758:0.006684:0.013257:0.013814:0.012384:0.013108:0.007390:0.008300:0.007260:0.016525:0.013777:0.008300:0.007260:0.006684:0.013777:0.013758:0.004809:0.013814:0.006239:0.007260:0.013777:0.007204:0.005143
copying the manufacturing processes :@0.522814:0.373661:0.905095:0.373661:0.905095:0.356018:0.522814:0.356018:0.012979:0.013108:0.013628:0.010918:0.004679:0.012273:0.013443:0.007130:0.007241:0.012273:0.013034:0.007130:0.018382:0.013647:0.012273:0.012236:0.006796:0.013647:0.012960:0.007241:0.012236:0.006536:0.004679:0.012273:0.013443:0.007130:0.013628:0.006536:0.013108:0.012979:0.013016:0.008170:0.008170:0.013016:0.007204:0.005143
was not that difficult. However, a stum-:@0.522814:0.389458:0.899952:0.389458:0.899952:0.371815:0.522814:0.371815:0.015986:0.013238:0.007761:0.006721:0.011883:0.012719:0.006851:0.006721:0.006851:0.011883:0.013238:0.006851:0.006721:0.013276:0.004270:0.006387:0.006387:0.004270:0.012570:0.011846:0.004270:0.006851:0.005700:0.006721:0.013238:0.012719:0.015986:0.012626:0.010843:0.012626:0.006146:0.005700:0.006721:0.013238:0.006721:0.007761:0.006851:0.011846:0.017973:0.006164
bling block was safety and efficacy, both :@0.522814:0.405256:0.905151:0.405256:0.905151:0.387613:0.522814:0.387613:0.012663:0.003713:0.003713:0.011326:0.012496:0.006034:0.012663:0.003713:0.012162:0.012013:0.009321:0.006016:0.015429:0.012681:0.007204:0.006034:0.007204:0.012681:0.005830:0.012069:0.006294:0.009952:0.006034:0.012681:0.011326:0.012719:0.006016:0.012069:0.005830:0.004521:0.004521:0.012013:0.012681:0.012013:0.009952:0.005143:0.006016:0.012663:0.012162:0.006294:0.011326:0.005143
of which are key to the licencing and :@0.522814:0.421053:0.905263:0.421053:0.905263:0.403410:0.522814:0.403410:0.013090:0.006758:0.007093:0.016358:0.012254:0.004642:0.012941:0.012254:0.007093:0.013610:0.006517:0.012997:0.007093:0.010249:0.012997:0.010880:0.007093:0.007223:0.013090:0.007093:0.007223:0.012254:0.012997:0.007093:0.004642:0.004642:0.012941:0.012997:0.012254:0.012941:0.004642:0.012254:0.013424:0.007093:0.013610:0.012254:0.012719:0.005143
regulation of products for use. For :@0.522814:0.436851:0.905058:0.436851:0.905058:0.419208:0.522814:0.419208:0.007668:0.014148:0.014575:0.013368:0.005812:0.014780:0.008374:0.005812:0.014241:0.013406:0.008262:0.014241:0.007910:0.008262:0.014761:0.007668:0.014241:0.014817:0.013368:0.014111:0.008374:0.009302:0.008262:0.007928:0.014241:0.007668:0.008262:0.013387:0.009302:0.014148:0.007223:0.008262:0.011085:0.014241:0.005589:0.005143
example, the European and US regulatory :@0.522814:0.452648:0.905170:0.452648:0.905170:0.435005:0.522814:0.435005:0.012069:0.008912:0.012681:0.017416:0.012663:0.003713:0.012069:0.005143:0.005032:0.006294:0.011326:0.012069:0.005032:0.009952:0.011289:0.005589:0.012162:0.012663:0.012069:0.012681:0.011326:0.005032:0.012681:0.011326:0.012719:0.005032:0.012162:0.009246:0.005032:0.005589:0.012069:0.012496:0.011289:0.003713:0.012681:0.006294:0.012162:0.005589:0.009952:0.005143
bodies only recently (namely March and :@0.522814:0.468446:0.905077:0.468446:0.905077:0.450803:0.522814:0.450803:0.012830:0.012329:0.012886:0.003881:0.012236:0.007371:0.006331:0.012329:0.011493:0.003881:0.010119:0.006331:0.005756:0.012236:0.012180:0.012236:0.011493:0.006461:0.003881:0.010119:0.006331:0.007018:0.011493:0.012849:0.017583:0.012236:0.003881:0.010119:0.006331:0.017230:0.012849:0.005756:0.012180:0.011493:0.006331:0.012849:0.011493:0.012719:0.005143
november 2015 respectively) finalised :@0.522814:0.484244:0.905133:0.484244:0.905133:0.466600:0.522814:0.466600:0.014687:0.013108:0.011233:0.013016:0.018363:0.013610:0.013016:0.006536:0.007111:0.011233:0.011233:0.011233:0.011233:0.007111:0.006536:0.013016:0.008151:0.013610:0.013016:0.012960:0.007241:0.004660:0.011233:0.013016:0.004660:0.010899:0.007798:0.007111:0.006777:0.004660:0.012273:0.013628:0.004660:0.004660:0.008151:0.013016:0.012719:0.005143
their respective regulations for insulin :@0.522814:0.500041:0.905114:0.500041:0.905114:0.482398:0.522814:0.482398:0.007445:0.012477:0.013220:0.004883:0.006740:0.007334:0.006740:0.013220:0.008355:0.013833:0.013220:0.013164:0.007445:0.004865:0.011456:0.013220:0.007334:0.006740:0.013220:0.013647:0.012440:0.004883:0.013833:0.007445:0.004883:0.013313:0.012477:0.008374:0.007334:0.006981:0.013313:0.006740:0.007334:0.004883:0.012477:0.008374:0.012440:0.004883:0.004865:0.011326:0.005143
copies of the original. :@0.522814:0.515839:0.721428:0.515839:0.721428:0.498196:0.522814:0.498196:0.012013:0.012162:0.012663:0.003713:0.012069:0.007204:0.005143:0.012162:0.005830:0.005143:0.006294:0.011326:0.012069:0.005143:0.012162:0.005589:0.003713:0.012496:0.003713:0.011326:0.012681:0.003713:0.005143:0.005143
The  main  question  relating  to  this :@0.540360:0.531636:0.905021:0.531636:0.905021:0.513993:0.540360:0.513993:0.009748:0.013164:0.013907:0.005143:0.002859:0.019254:0.014520:0.005552:0.013164:0.005143:0.002859:0.014501:0.013127:0.013907:0.009042:0.008132:0.005552:0.014000:0.013164:0.005143:0.002859:0.007427:0.013907:0.005552:0.014520:0.008132:0.005552:0.013164:0.014334:0.005143:0.002859:0.008132:0.014000:0.005143:0.002859:0.008132:0.013164:0.005552:0.007204:0.005143
process of copying original biologicals is: :@0.522814:0.547434:0.905151:0.547434:0.905151:0.529791:0.522814:0.529791:0.012849:0.005756:0.012329:0.012180:0.012236:0.007390:0.007390:0.006350:0.012329:0.005997:0.006350:0.012180:0.012329:0.012849:0.010138:0.003899:0.011493:0.012663:0.006350:0.012329:0.005756:0.003899:0.012663:0.003899:0.011493:0.012867:0.003899:0.006350:0.012849:0.003899:0.012329:0.003899:0.012329:0.012663:0.003899:0.012180:0.012867:0.003899:0.007390:0.006350:0.003899:0.007390:0.005143:0.005143
“Are they the same as the originator?” The :@0.522814:0.563231:0.905151:0.563231:0.905151:0.545588:0.522814:0.545588:0.009321:0.013740:0.005589:0.012069:0.004456:0.006294:0.011326:0.012069:0.009952:0.004456:0.006294:0.011326:0.012069:0.004456:0.007204:0.012681:0.017416:0.012069:0.004475:0.012681:0.007204:0.004475:0.006294:0.011326:0.012069:0.004456:0.012162:0.005589:0.003713:0.012496:0.003713:0.011326:0.012681:0.006294:0.012162:0.005589:0.010973:0.008987:0.004438:0.007910:0.011326:0.012069:0.005143
answer to this is not easy as these mole-:@0.522814:0.579029:0.899767:0.579029:0.899767:0.561386:0.522814:0.561386:0.013016:0.011660:0.007538:0.015764:0.012403:0.005923:0.006499:0.006629:0.012496:0.006499:0.006629:0.011660:0.004048:0.007538:0.006499:0.004048:0.007538:0.006499:0.011660:0.012496:0.006629:0.006499:0.012403:0.013016:0.007538:0.010286:0.006499:0.013016:0.007538:0.006499:0.006629:0.011660:0.012403:0.007538:0.012403:0.006499:0.017750:0.012496:0.004048:0.012403:0.006164
cules vary significantly in size and structure – :@0.522814:0.594827:0.905188:0.594827:0.905188:0.577183:0.522814:0.577183:0.011827:0.011103:0.003528:0.011883:0.007018:0.003806:0.010101:0.012496:0.005403:0.009766:0.003806:0.007018:0.003528:0.012310:0.011140:0.003528:0.004428:0.004428:0.011827:0.012496:0.011140:0.006109:0.003528:0.009766:0.003806:0.003528:0.011140:0.003806:0.007018:0.003528:0.007705:0.011883:0.003806:0.012496:0.011140:0.012533:0.003806:0.007018:0.006109:0.005403:0.011103:0.011827:0.006109:0.011103:0.005403:0.011883:0.003806:0.009284:0.005143
 :@0.900008:0.594827:0.905151:0.594827:0.905151:0.577183:0.900008:0.577183:0.005143
e.g., insulin is a c 6 000 Dalton protein :@0.522814:0.610624:0.905021:0.610624:0.905021:0.592981:0.522814:0.592981:0.012941:0.006016:0.013368:0.006016:0.006016:0.007037:0.004586:0.012199:0.008077:0.012162:0.004586:0.004586:0.012199:0.007037:0.004586:0.008077:0.007037:0.013554:0.007037:0.012886:0.007037:0.011159:0.007037:0.011159:0.011159:0.011159:0.007037:0.014687:0.013554:0.004586:0.007167:0.013034:0.012199:0.007037:0.013536:0.006461:0.013034:0.007167:0.012941:0.004586:0.011326:0.005143
consisting mainly of two side chains with :@0.522814:0.626422:0.904947:0.626422:0.904947:0.608778:0.522814:0.608778:0.012292:0.012440:0.011605:0.007483:0.003992:0.007483:0.006573:0.003992:0.011605:0.012774:0.006443:0.017695:0.012960:0.003992:0.011605:0.003992:0.010231:0.006443:0.012440:0.006109:0.006443:0.006573:0.015708:0.012440:0.006443:0.007483:0.003992:0.012997:0.012347:0.006443:0.012292:0.011605:0.012960:0.003992:0.011605:0.007483:0.006443:0.015708:0.003992:0.006573:0.011326:0.005143
rather simple interconnecting disulphide :@0.522814:0.642219:0.905207:0.642219:0.905207:0.624576:0.522814:0.624576:0.005923:0.013034:0.006647:0.011660:0.012422:0.005923:0.006517:0.007557:0.004066:0.017769:0.013016:0.004066:0.012422:0.006517:0.004066:0.011660:0.006629:0.012422:0.005923:0.012366:0.012496:0.011679:0.011660:0.012422:0.012366:0.006647:0.004066:0.011679:0.012830:0.006517:0.013071:0.004066:0.007557:0.011642:0.004066:0.013016:0.011660:0.004066:0.013071:0.012069:0.005143
bonds, whereas a monoclonal antibody :@0.522814:0.658017:0.905133:0.658017:0.905133:0.640374:0.522814:0.640374:0.013016:0.012496:0.011660:0.013071:0.007557:0.005477:0.006517:0.015782:0.011660:0.012403:0.005923:0.012403:0.013034:0.007557:0.006517:0.013034:0.006517:0.017769:0.012496:0.011660:0.012496:0.012366:0.004066:0.012496:0.011660:0.013034:0.004066:0.006517:0.013034:0.011660:0.006629:0.004066:0.013016:0.012496:0.013071:0.009952:0.005143
(e.g., trastuzumab [Herceptin ] used for :@0.522814:0.673814:0.905119:0.674011:0.905119:0.656367:0.522814:0.656171:0.007316:0.012533:0.005607:0.012960:0.005607:0.005607:0.006629:0.006758:0.006053:0.013146:0.007668:0.006758:0.011753:0.008355:0.011753:0.017880:0.013146:0.013127:0.006629:0.006981:0.013146:0.012533:0.006053:0.012477:0.012533:0.013127:0.006758:0.004178:0.011326:0.008880:0.006981:0.006629:0.011753:0.007668:0.012533:0.013183:0.006629:0.006294:0.012626:0.005589:-0.405626
®:@0.801732:0.668061:0.809818:0.668061:0.809818:0.657775:0.801732:0.657775:0.008086
the treatment of Her2 breast cancer :@0.522800:0.689808:0.905185:0.689805:0.905185:0.672162:0.522800:0.672165:0.007724:0.012756:0.013517:0.007613:0.007724:0.007018:0.013517:0.014130:0.007743:0.018864:0.013517:0.012756:0.007724:0.007613:0.013591:0.007278:0.007613:0.014130:0.013498:0.007018:0.010286:0.005915:0.014111:0.007018:0.013517:0.014130:0.008652:0.007743:0.007613:0.013461:0.014130:0.012756:0.013461:0.013517:0.005589:-0.428415
 :@0.749907:0.683855:0.752906:0.683855:0.752906:0.673569:0.749907:0.673569:0.002998
patients) is a 160 000 Dalton molecule with :@0.522811:0.705603:0.905148:0.705603:0.905148:0.687960:0.522811:0.687960:0.012663:0.012681:0.006294:0.003713:0.012069:0.011326:0.006294:0.007204:0.006851:0.004512:0.003713:0.007204:0.004512:0.012681:0.004512:0.010286:0.010286:0.010286:0.004512:0.010286:0.010286:0.010286:0.004512:0.013814:0.012681:0.003713:0.006294:0.012162:0.011326:0.004512:0.017416:0.012162:0.003713:0.012069:0.012013:0.011289:0.003713:0.012069:0.004512:0.015429:0.003713:0.006294:0.011326:0.005143
complex folding and very specific :@0.522811:0.721401:0.905092:0.721401:0.905092:0.703757:0.522811:0.703757:0.014130:0.014278:0.019533:0.014780:0.005830:0.014185:0.011029:0.008281:0.007947:0.014278:0.005830:0.014835:0.005830:0.013443:0.014612:0.008281:0.014798:0.013443:0.014835:0.008281:0.012403:0.014185:0.007705:0.012069:0.008281:0.009321:0.014780:0.014185:0.014130:0.005830:0.007947:0.005830:0.012013:0.005143
receptor target sites. This is in stark contrast :@0.522811:0.737198:0.905148:0.737198:0.905148:0.719555:0.522811:0.719555:0.005589:0.012069:0.012013:0.012069:0.012663:0.006294:0.012162:0.005589:0.004400:0.006294:0.012681:0.005589:0.012496:0.012069:0.006294:0.004419:0.007204:0.003713:0.006294:0.012069:0.007204:0.005143:0.004419:0.007910:0.011326:0.003713:0.007204:0.004419:0.003713:0.007204:0.004438:0.003713:0.011326:0.004419:0.007204:0.006294:0.012681:0.005589:0.009321:0.004419:0.012013:0.012162:0.011326:0.006294:0.005589:0.012681:0.007204:0.006294:0.005143
to the typical small chemical entity, e.g., :@0.522811:0.752996:0.905055:0.752996:0.905055:0.735352:0.522811:0.735352:0.006443:0.012310:0.006331:0.006443:0.011475:0.012217:0.006331:0.006443:0.010101:0.012811:0.003881:0.012162:0.012830:0.003881:0.006331:0.007353:0.017565:0.012830:0.003881:0.003881:0.006331:0.012162:0.011475:0.012217:0.017565:0.003881:0.012162:0.012830:0.003881:0.006331:0.012217:0.011475:0.006443:0.003881:0.006443:0.010101:0.005292:0.006331:0.012217:0.005292:0.012644:0.005292:0.005143:0.005143
aspirin which is 180 Dalton in size. With this :@0.522811:0.768793:0.905111:0.768793:0.905111:0.751150:0.522811:0.751150:0.012681:0.007204:0.012663:0.003713:0.005589:0.003713:0.011326:0.005756:0.015429:0.011326:0.003713:0.012013:0.011326:0.005737:0.003713:0.007204:0.005737:0.010286:0.010286:0.010286:0.005756:0.013814:0.012681:0.003713:0.006294:0.012162:0.011326:0.005737:0.003713:0.011326:0.005737:0.007204:0.003713:0.007891:0.012069:0.005143:0.005737:0.017825:0.003713:0.006294:0.011326:0.005737:0.006294:0.011326:0.003713:0.007204:0.005143
complexity and size, replicating these :@0.522811:0.784591:0.905222:0.784591:0.905222:0.766948:0.522811:0.766948:0.012979:0.013127:0.018382:0.013628:0.004679:0.013034:0.009878:0.004679:0.007260:0.010918:0.007130:0.013647:0.012292:0.013684:0.007130:0.008170:0.004679:0.008857:0.013034:0.006109:0.007130:0.006554:0.013034:0.013628:0.004679:0.004679:0.012979:0.013647:0.007260:0.004679:0.012292:0.013461:0.007130:0.007260:0.012292:0.013034:0.008170:0.012069:0.005143
entities has very specific challenges, i.e., :@0.522811:0.800388:0.905166:0.800388:0.905166:0.782745:0.522811:0.782745:0.012329:0.011586:0.006554:0.003973:0.006554:0.003973:0.012329:0.007464:0.006424:0.011586:0.012941:0.007464:0.006424:0.010546:0.012329:0.005849:0.010212:0.006424:0.007464:0.012923:0.012329:0.012273:0.003973:0.004651:0.004651:0.012273:0.006424:0.012273:0.011586:0.012941:0.003973:0.003973:0.012329:0.011586:0.012756:0.012329:0.007464:0.005403:0.006424:0.003973:0.005403:0.012329:0.005403:0.005143:0.005143
the more modern manufacturing since :@0.522811:0.816186:0.905073:0.816186:0.905073:0.798543:0.522811:0.798543:0.007000:0.012032:0.012774:0.006870:0.018122:0.012867:0.006294:0.012774:0.006870:0.018122:0.012867:0.013424:0.012774:0.006294:0.012032:0.006870:0.018122:0.013387:0.012032:0.011994:0.006536:0.013387:0.012719:0.007000:0.011994:0.006294:0.004419:0.012032:0.013201:0.006870:0.007910:0.004419:0.012032:0.012719:0.012069:0.005143
the initial molecule was patented 20 years :@0.522811:0.831983:0.905129:0.831983:0.905129:0.814340:0.522811:0.814340:0.006294:0.011326:0.012069:0.004716:0.003713:0.011326:0.003713:0.006294:0.003713:0.012681:0.003713:0.004735:0.017416:0.012162:0.003713:0.012069:0.012013:0.011289:0.003713:0.012069:0.004735:0.015429:0.012681:0.007204:0.004735:0.012663:0.012681:0.006294:0.012069:0.011326:0.006294:0.012069:0.012719:0.004735:0.010286:0.010286:0.004735:0.009952:0.012069:0.012681:0.005589:0.007204:0.005143
ago, as well as the challenge that the :@0.522811:0.847781:0.905203:0.847781:0.905203:0.830138:0.522811:0.830138:0.013480:0.013294:0.012960:0.005942:0.006963:0.013480:0.008002:0.006963:0.016228:0.012867:0.004512:0.004512:0.006963:0.013480:0.008002:0.006963:0.007093:0.012124:0.012867:0.006963:0.012811:0.012124:0.013480:0.004512:0.004512:0.012867:0.012124:0.013294:0.012867:0.006963:0.007093:0.012124:0.013480:0.007093:0.006963:0.007093:0.012124:0.012069:0.005143
factory of these proteins essentially :@0.522811:0.863579:0.905203:0.863579:0.905203:0.845935:0.522811:0.845935:0.007501:0.014352:0.013684:0.007965:0.013833:0.007260:0.011623:0.007835:0.013833:0.007501:0.007835:0.007965:0.012997:0.013740:0.008875:0.013740:0.007835:0.014334:0.007260:0.013833:0.007965:0.013740:0.005385:0.012997:0.008875:0.007835:0.013740:0.008875:0.008875:0.013740:0.012997:0.007965:0.005385:0.014352:0.005385:0.005385:0.009952:0.005143
consists of other living cells. Recombinant :@0.522811:0.879376:0.905147:0.879342:0.905147:0.861699:0.522811:0.861733:0.012124:0.012254:0.011419:0.007316:0.003825:0.007316:0.006387:0.007316:0.006276:0.012254:0.005942:0.006276:0.012254:0.006387:0.011419:0.012180:0.005682:0.006276:0.003825:0.003825:0.010398:0.003825:0.011419:0.012589:0.006276:0.012106:0.012180:0.003825:0.003825:0.007316:0.005143:0.003769:0.011382:0.012162:0.012124:0.012254:0.017528:0.012774:0.003825:0.011419:0.012793:0.011419:0.006294:-0.701045
 :@0.772373:0.873392:0.775372:0.873392:0.775372:0.863106:0.772373:0.863106:0.002998
DnA technology has allowed the transfer :@0.522810:0.895140:0.904962:0.895140:0.904962:0.877497:0.522810:0.877497:0.013851:0.013777:0.013777:0.006201:0.006331:0.012106:0.012050:0.011363:0.011363:0.012199:0.003751:0.012199:0.012533:0.009989:0.006201:0.011363:0.012719:0.007241:0.006201:0.012719:0.003751:0.003751:0.012199:0.015467:0.012106:0.012756:0.006201:0.006331:0.011363:0.012106:0.006201:0.006331:0.005626:0.012719:0.011363:0.007241:0.005867:0.012106:0.005589:0.005143
of specific DNA segments from the human :@0.522810:0.910937:0.905147:0.910937:0.905147:0.893294:0.522810:0.893294:0.012162:0.005830:0.004735:0.007204:0.012663:0.012069:0.012013:0.003713:0.004521:0.004521:0.012013:0.004735:0.013814:0.013740:0.013740:0.004735:0.007204:0.012069:0.012496:0.017416:0.012069:0.011326:0.006294:0.007204:0.004735:0.005830:0.005589:0.012162:0.017398:0.004735:0.006294:0.011326:0.012069:0.004735:0.011326:0.011289:0.017416:0.012681:0.011326:0.005143
host to a bacterial or yeast cell, with the :@0.522810:0.926735:0.905222:0.926735:0.905222:0.909092:0.522810:0.909092:0.011549:0.012384:0.007427:0.006517:0.006387:0.006517:0.012384:0.006387:0.012904:0.006387:0.012886:0.012904:0.012236:0.006517:0.012292:0.005812:0.003936:0.012904:0.003936:0.006387:0.012384:0.005812:0.006387:0.010175:0.012292:0.012904:0.007427:0.006517:0.006387:0.012236:0.012292:0.003936:0.003936:0.005366:0.006387:0.015652:0.003936:0.006517:0.011549:0.006387:0.006517:0.011549:0.012069:0.005143
Biosimilars: Should we Embrace  :@0.102339:0.123812:0.755866:0.123812:0.755866:0.082827:0.102339:0.082827:0.023931:0.009903:0.026407:0.018155:0.009903:0.038785:0.009903:0.009903:0.027232:0.013203:0.018155:0.011553:0.011553:0.021456:0.024756:0.026407:0.024756:0.009903:0.027232:0.011553:0.037135:0.026407:0.011553:0.021456:0.038785:0.027232:0.013203:0.027232:0.026407:0.026407:0.011512:0.011553
the New Biotechnology Medicines? :@0.102339:0.155361:0.820274:0.155361:0.820274:0.114376:0.102339:0.114376:0.012378:0.024756:0.026407:0.011553:0.030533:0.026407:0.033008:0.011553:0.023931:0.009903:0.026407:0.012378:0.026407:0.026407:0.024756:0.024756:0.026407:0.009903:0.026407:0.027232:0.023931:0.011553:0.037135:0.026407:0.027232:0.009903:0.026407:0.009903:0.024756:0.026407:0.018155:0.023106:0.011553